Lorazepam and diazepam rapidly relieve catatonic features in major depression

Clinical Neuropharmacology

Volumn 29, Issue 3, 2006, Pages 144-147

  Hung, Yi Yung ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Catatonia; Diazepam; Lorazepam; Major depressive disorder

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; LORAZEPAM; SODIUM CHLORIDE;

ADULT; ARTICLE; CATATONIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ELECTROCONVULSIVE THERAPY; EMERGENCY WARD; FEMALE; GENERAL HOSPITAL; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT INDICATION; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TIME;

ADULT; CATATONIA; DEPRESSIVE DISORDER, MAJOR; DIAZEPAM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; TIME FACTORS;

EID: 33746424053     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNF.0000221908.56361.C7     Document Type: Article

References (27)

1. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1233-1241.
2. Carroll BT, Carroll TD. Catatonia is the Rosetta Stone of psychosis. Behav Brain Sci 2005;28(6):759-760.
3. Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J 2001;24:522-525.
4. Koussa S, Nasnas R. Catatonia and parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case report. J Neurol 2003;250:103-105.
5. Elia J, Dell ML, Friedman DF, et al. Pandas with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry 2005;44:1145-1150.
6. Huffman JC, Fricchione GL. Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole. J Clin Psychopharmacol 2005;25:508-510.
7. Lee JW, Schwartz DL. Catatonia associated with hyponatremia. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:63-64.
8. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord 1993;29:255-261.
9. Hawkins JM, Archer KJ, Strakowski SM, et al. Somatic treatment of catatonia. Int J Psychiatry Med 1995;25(4):345-369.
10. Ungvari GS, Kau LS, Wai-Kwong T, et al. The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001;251(Suppl 1):I31-I34.
11. Bush G, Fink M, Petrides G, et al. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143.
12. Huang TL, Ree SC, Huang YC, et al. Catatonic features: differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci 1999;53:63-66.
13. Fink M, Taylor MA. The differential diagnosis of catatonia. In: Fink M, et al ed. Catatonia: A Clinician's Guide to Diagnosis and Treatment, 1st ed. Cambridge, MA: Cambridge University Press, 2003:71-113.
14. Starkstein SE, Petracca G, Teson A, et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 1996;60:326-332.
15. Huang TL. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005;59:52-55.
16. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-362.
17. Petrides G, Malur C, Fink M. Convulsive therapy. In: Caroff SN, et al. eds. Catatonia: From Psychopathology to Neurobiology, 1st. ed. Arlington, VA: American Psychiatric Publishing Inc, 2004:151-160.
18. Abrams R. Electroconvulsive Therapy, 4th. ed. New York, NY: Oxford University Press, 2002.
19. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002;25:555-577.
20. Brambilla P, Perez J, Barale F, et al. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721-737.
21. Sanacora G, Gueorguieva R, Epperson CN, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004;61:705-713.
22. Abi-Saab WM, Bubser M, Roth RH, et al. 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 1999;20:92-96.
23. Fatemi SH, Stary JM, Earle JA, et al. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res 2005;72:109-122.
24. Roy-Byrne PP. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety. J Clin Psychiatry 2005;66(Suppl 2):14-20.
25. Northoff G, Steinke R, Cszervenka C. Decreased density of GABAA receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999;67:445-450.
26. Carroll BT. GABAa versus GABAb hypothesis of catatonia. Mov Disord 1999;14:702-703.
27. Martire M, Altobelli D, Cannizzaro C, et al. Prenatal diazepam exposure functionally alters the GABA (A) receptor that modulates [3H] noradrenaline release from rat hippocampal synaptosomes. Dev Neurosci 2002;24:71-78.